LBRX Earnings Date: Nov 5, 2026 (Estimated) — LB Pharmaceuticals Inc Common Stock
NASDAQ · Healthcare · Biotechnology
Updated
When is LBRX's next earnings date?
LB Pharmaceuticals Inc Common Stock (LBRX) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.62.
How did LBRX do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), LB Pharmaceuticals Inc Common Stock posted EPS of -$1.71 versus the -$0.80 estimate, a miss of 111.1%. Revenue was $0. The stock's 1-day post-earnings move was -1.1%.
How much does LBRX stock move after earnings?
LBRX beat EPS estimates in 1 of its last 4 reported quarters. Over the last 4 reports the stock moved an average of 3.0% (up or down) in the day after earnings.
About LB Pharmaceuticals Inc Common Stock
This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.80 | -1.71 | -111.11% | $0 | ❌ Miss | -1.13% | +0.83% | +3.97% |
| 2026-05-12 | Q1 2026 | -0.69 | -0.67 | +2.90% | $0 | ✅ Beat | +3.79% | -12.40% | -8.32% |
| 2026-03-26 | Q4 2025 | -0.37 | -0.45 | -21.62% | $0 | ❌ Miss | -2.81% | +4.73% | +29.68% |
| 2025-11-06 | Q3 2025 | -0.57 | -0.61 | -7.02% | $0 | ❌ Miss | -4.26% | -6.91% | +20.37% |
Showing last 4 quarters.